NBP608
Sponsors
SK Bioscience Co., Ltd., SK Chemicals Co., Ltd.
Conditions
Herpes ZosterVaricella
Phase 2
The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age
CompletedNCT03114982
Start: 2016-05-31End: 2016-11-30Updated: 2017-04-14
Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over
CompletedNCT03116594
Start: 2014-01-03End: 2015-03-07Updated: 2017-04-17
Phase 3
Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age
CompletedNCT03114943
Start: 2016-07-14End: 2017-06-28Updated: 2019-05-08
Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over
CompletedNCT03120364
Start: 2015-09-09End: 2016-04-28Updated: 2017-04-19